Universal Technical Institute (UTI) delivered a solid QQ3 2024 performance with revenue of $177.5 million, up 15.8% year over year, driven by strong growth in both divisions and ongoing program expansions. Consolidated EBITDA reached $18.4 million (up ~61% YoY), with net income of $5.0 million and diluted EPS of $0.09. The Concorde division posted robust start dynamics, including a ~35% YoY rise in clinical starts, while the UTI division experienced a timing-driven start shift (June to July) that moderated quarterly starts but supported full-year expectations. Management reaffirmed guidance at the upper end of revenue and new student start ranges and outlined Phase 2 of the North Star Strategy, including at least six new programs per year and the potential opening of two new campuses annually starting in 2026, targeting roughly 10% revenue CAGR to 2029 and an EBITDA margin approaching 20% by 2029. A notable near-term development is the Heartland Dental co-branded campus initiative in Fort Myers (Fall 2025) with Title IV funding ambitions once growth restrictions are lifted, underscoring a stronger partner-led growth model. The company also reiterated its emphasis on operating leverage, capital discipline, and selective acquisitions, positioning UTIs to capitalize on the growing demand for skilled labor in transportation, trades, and healthcare.